Literature DB >> 20567845

Strength of molecular cytogenetic analyses for adjusting the diagnosis of renal cell carcinomas with both clear cells and papillary features: a study of three cases.

Juliette Haudebourg1, Benjamin Hoch, Thibault Fabas, Nathalie Cardot-Leccia, Fanny Burel-Vandenbos, Annick Vieillefond, Jean Amiel, Jean-François Michiels, Florence Pedeutour.   

Abstract

Histological features are usually sufficient for providing an accurate diagnosis of renal cell carcinomas (RCC). However, the morphological appearance might sometimes be misleading. For instance, RCC with papillary areas and extensive clear cell changes may be difficult to classify either as clear cell renal carcinoma or as papillary renal cell carcinoma (pRCC). We used the combination of immunohistochemistry, conventional cytogenetics, fluorescence in situ hybridization (FISH), bacterial artificial chromosomes comparative genomic hybridization arrays and high-density single nucleotides polymorphism arrays (SNP arrays) to characterize three cases of RCC showing a predominant cytology of cells with clear cytoplasm and variable amounts of papillary areas. In accordance with the 2004 World Health Organization (WHO) classification, we initially assessed the diagnosis of clear cell RCC for one of the cases and unclassified RCC for the two remaining cases. However, because of a strong immunohistochemical labeling for alpha-methylacyl-CoA racemase, as well as the presence of a gain of chromosomes 7 and 17, we concluded that two of these tumors were actually pRCC. As for the third case, because of the presence of both pCCR and ccCCR molecular cytogenetic aberrations, including gains of chromosomes 7 and 17, loss of chromosome Y and whole chromosome 3 loss of heterozyosity (isodisomy), the final diagnosis was hybrid tumor cc-pRCC, so-called "unclassified RCC" according to the WHO classification. Our observations demonstrate the necessity to use immunohistochemical and cytogenetic tools in all cases of RCC showing unusual features. The combination of FISH and SNP arrays is prevailing for characterizing cases with hybrid features.

Entities:  

Mesh:

Year:  2010        PMID: 20567845     DOI: 10.1007/s00428-010-0937-1

Source DB:  PubMed          Journal:  Virchows Arch        ISSN: 0945-6317            Impact factor:   4.064


  18 in total

1.  Characterization of centromere alterations in liposarcomas.

Authors:  N Sirvent; A Forus; W Lescaut; F Burel; S Benzaken; M Chazal; A Bourgeon; J R Vermeesch; O Myklebost; C Turc-Carel; N Ayraud; J M Coindre; F Pedeutour
Journal:  Genes Chromosomes Cancer       Date:  2000-10       Impact factor: 5.006

2.  Application of long-term collagenase disaggregation for the cytogenetic analysis of human solid tumors.

Authors:  J Limon; P Dal Cin; A A Sandberg
Journal:  Cancer Genet Cytogenet       Date:  1986-12

Review 3.  Translocation carcinomas of the kidney.

Authors:  Pedram Argani; Marc Ladanyi
Journal:  Clin Lab Med       Date:  2005-06       Impact factor: 1.935

4.  Papillary renal cell carcinoma with clear cell cytomorphology and chromosomal loss of 3p.

Authors:  L Füzesi; B Gunawan; F Bergmann; S Tack; S Braun; G Jakse
Journal:  Histopathology       Date:  1999-08       Impact factor: 5.087

5.  Malignant papillary renal tumors with extensive clear cell change: a molecular analysis by microsatellite analysis and fluorescence in situ hybridization.

Authors:  M E Salama; M J Worsham; M DePeralta-Venturina
Journal:  Arch Pathol Lab Med       Date:  2003-09       Impact factor: 5.534

6.  Cytogenetic studies of tumor tissue from patients with nonfamilial renal cell carcinoma.

Authors:  M A Yoshida; K Ohyashiki; H Ochi; Z Gibas; J E Pontes; G R Prout; R Huben; A A Sandberg
Journal:  Cancer Res       Date:  1986-04       Impact factor: 12.701

7.  Chromosomal abnormalities in non-neoplastic renal tissue.

Authors:  E van den Berg; T Dijkhuizen; S Störkel; W M Molenaar; B de Jong
Journal:  Cancer Genet Cytogenet       Date:  1995-12

8.  Cytogenetic profile predicts prognosis of patients with clear cell renal cell carcinoma.

Authors:  Tobias Klatte; P Nagesh Rao; Michela de Martino; Jeffrey LaRochelle; Brian Shuch; Nazy Zomorodian; Jonathan Said; Fairooz F Kabbinavar; Arie S Belldegrun; Allan J Pantuck
Journal:  J Clin Oncol       Date:  2009-01-05       Impact factor: 44.544

9.  Virtual-karyotyping with SNP microarrays in morphologically challenging renal cell neoplasms: a practical and useful diagnostic modality.

Authors:  Hyun-Jung Kim; Steven S Shen; Alberto G Ayala; Jae Y Ro; Luan D Truong; Karla Alvarez; Julia A Bridge; Zoran Gatalica; Jill M Hagenkord; José M Gonzalez-Berjon; Federico A Monzon
Journal:  Am J Surg Pathol       Date:  2009-09       Impact factor: 6.394

10.  Virtual karyotyping with SNP microarrays reduces uncertainty in the diagnosis of renal epithelial tumors.

Authors:  Jill M Hagenkord; Anil V Parwani; Maureen A Lyons-Weiler; Karla Alvarez; Robert Amato; Zoran Gatalica; Jose M Gonzalez-Berjon; Leif Peterson; Rajiv Dhir; Federico A Monzon
Journal:  Diagn Pathol       Date:  2008-11-06       Impact factor: 2.644

View more
  4 in total

1.  Clonal trisomies 7,10 and 12, normal 3p and absence of VHL gene mutation in a clear cell tubulopapillary carcinoma of the kidney.

Authors:  Alexander Wolfe; Sheila M Dobin; Petr Grossmann; Michal Michal; Ludvik R Donner
Journal:  Virchows Arch       Date:  2011-08-07       Impact factor: 4.064

2.  Foamy cell (hibernoma-like) change is a rare histopathological feature in renal cell carcinoma.

Authors:  Fredrik Petersson; Maris Sperga; Stela Bulimbasic; Petr Martinek; Marian Svajdler; Naoto Kuroda; Milan Hora; Roderick Simpson; Tomáš Tichy; Kvetoslava Peckova; Jindrich Branzovsky; Kristyna Pivovarcikova; Pavla Rotterova; Bohuslava Kokoskova; Kevin Bauleth; Dusan Martincok; Vincent Nagy; Michal Michal; Ondrej Hes
Journal:  Virchows Arch       Date:  2014-06-06       Impact factor: 4.064

Review 3.  Clear cell papillary renal cell carcinoma: a review.

Authors:  Naoto Kuroda; Chisato Ohe; Fumi Kawakami; Shuji Mikami; Mitsuko Furuya; Keiko Matsuura; Masatsugu Moriyama; Yoji Nagashima; Ming Zhou; Fredrik Petersson; José I López; Ondrej Hes; Michal Michal; Mahul B Amin
Journal:  Int J Clin Exp Pathol       Date:  2014-10-15

4.  Molecular subtyping of metastatic renal cell carcinoma: implications for targeted therapy.

Authors:  Lisha Wang; Sean R Williamson; Mingsheng Wang; Darrell D Davidson; Shaobo Zhang; Lee Ann Baldridge; Xiang Du; Liang Cheng
Journal:  Mol Cancer       Date:  2014-02-26       Impact factor: 27.401

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.